a fact which both affords support to the theory of the mechanism of inactivation, and gives promise for the therapeutic efficacy of mercaptans in the treatment of mercury poisoning. The present report is concerned with the efficacy of BAL, BAL glucoside and thiosorbitol in the treatment of experimental, acute, systemic mercury poisoning in rabbits and dogs.
The reactions between mercaptans and Hg++ in uitro
The reactions between mercaptans and cationic mercury which occur in vitro are presumably indicative of the expected interaction of the two agents in vivo. A brief study of the chemical reactions between the various mercaptans and mercury was, therefore, undertaken.
Reactions zvith BAL. When solutions of HgCl, (0.1 M) were added to non-buffered, aqueous solutions of BAL (0.05 M) a copious, flocculent white precipitate formed. Titration with phenolphthalein as an indicator revealed the formation of 2 equivalents of H+ for each mol of HgCl, added. The white precipitate was insoluble in alkali, but could be dissolved upon the addition of concentrated Ha. On the basis of analogy to the reactions of BAL with arsenicals (2,3) the complex (hereafter called Hg-BAL) presumably possessed, the following structure:
H HC-S /g HC-S HCOH H The complex was sufficiently dissociable so that the addition of neutral solutions of Na,S to a suspension of the mercaptide resulted in the formation of a copious, black precipitate of HgS.
Of greater importance than the formation of the insoluble Hg-BAL complex, was the reaction which took 549 Downloaded from http://www.jci.org on April 1, 2017. https://doi.org/10.1172/JCI101737 place when Hgl was introduced into alkaline solutions of BAL maintained at pH 7.5. Under these conditions the addition of Hg" in the molar proportion of 1 Hg: 2 BAL resulted in the formation of a complex which was soluble and so little dissociated that the addition of neutral solutions of Na2S did not * BAL and 1-Thiosorbitol given in 3 equally divided doses, the first, intravenously, and the second and third, intramuscularly, respectively 1 and 3 hours later. Any subsequent doses were given at 2-hour intervals. BAL glucoside given similarly, except that all injections were intravenous. BAL administered in propylene glycol (0.5 mM. per ml. 20 per cent, and prevent renal damage in the majority of surviving animals.
The adverse effect of a delay in treatment can be seen from the data in Table II . In the rabbit, a therapeutic delay of 30 minutes resulted in an incidence of renal insufficiency of close to 100 per cent. However, all 3 mercaptans were still capable of preventing the death of. a high proportion of animals. The data at 30 minutes suggest that increasing the total dose of BAL by extending the period of treatment afforded no greater protection. If treatment was delayed for 60 minutes only an occasional animal survived.
The toxicity of the preformed complexes Information on the basic mechanism involved in the treatment of mercury poisoning by mer- with evidence of massive pulmonary edema. The fact that mercury administered intravenously can damage the pulmonary capillary bed has also been observed by Rosenthal (4) . The evaluation of BAL in the treatment of acute intravenous mercury poisoning in the dog is complicated by the fact that approximately 50 per cent of animals, treated within the first hour, die acutely during the first day of massive pulmonary edema (Table  IV) . It is known that BAL itself is capable of producing pulmonary edema as a result of a direct toxic action on the capillaries (5). Although the dose of BAL necessary to produce acute deaths from its action on the pulmonary circulation is greatly in excess of that employed in the present study, nevertheless, the possibility of a synergistic action of BAL and mercury on the pulmonary capillary bed must be considered. When dogs which had received oral mercury were treated 2 hours later with BAL, a high degree of protection was afforded (Table V) . Six of 10 animals survived. What is more, as can be seen from Table VI , only 1 of the 10 animals showed evidence of renal insufficiency as judged by a significant rise in the level of serum urea N.
In those dogs which died, death could be attributed to a severe hemorrhagic gastro-enteritis. Even more striking results were obtained when treatment with BAL glucoside was instituted 2 hours after the administration of HgCl,. Of 8 treated animals, only 1 succumbed, and in this dog there was no evidence of a significant degree of renal impairment at 48 hours (Table VI) .
When BAL was administered 3 hours after HgCl2, 7 of 15 treated animals succumbed. Again only 2 dogs showed elevated serum urea N levels at 48 hours; 1 animal had a level of only 44 mgm.
per cent-and died 6 hours later. This animal was dehydrated from a bloody diarrhea. The second dog showed a progressive rise in serum urea N. In none of the 5 remaining dogs which succumbed could death be attributed to the toxic actions of mercury on the kidney. Of the 5 animals treated with BAL 5 hours after the administration of HgCl2, 3 survived. The 2 deaths occurred on the third and fourth days in animals with 48-hour serum urea N levels of 57 and 52 mgm. per cent, respectively. BAL glucoside was also highly effective when given 5 hours after oral poisoning with mercury. Two of 6 animals succumbed, 1 within 24 hours and the other within 48 hours; both exhibited a severe hemorrhagic enteritis. Of the 4 surviving animals, none showed evidence of systemic mercury poisoning.
DISCUSSION
It is evident-from the above data that the 3 mercaptans investigated were able to protect against the systemic effects of mercury, even when treatment was delayed. In view of the ability of these compounds to form mercaptides in vitro, it must be assumed that similar reactions occur in vivo. Moreover, the fact that early treatment with mercaptans affords complete protection, indicates that the mercaptides formed in vivo are sufficiently non-dissociated to prevent combination of Hg++ with essential cellular enzymes. Lastly, the observation that the dithiols are therapeutically effective when administered 2 to 3 hours after intravenous mercury in dogs, indicates that the dithiols can remove mercury already combined intracellularly.
Of the 3 mercaptans studied, the order of decreasing efficacy was BAL glucoside, BAL, and thiosorbitol. Thiosorbitol possesses certain pharmaceutical advantages over BAL in that it is a crystalline, water-soluble compound which may be readily administered by intravenous injection. Although it is much less toxic than BAL in mice and rabbits, the greater efficacy of BAL at dose levels which are well within the range of human tolerance (3) favors the choice of the dithiol for clinical use. The fact that the monothiols were less effective than the dithiols in reversing arsenic linkage with proteins has been demonstrated by British investigators (2) . By analogy, monothiols might be expected to be less effective in the treatment of mercury poisoning. The in vitro observations reported above indicated a greater dissociation of Hg(thiosorbitol)2 than of either Hg-(BAL)2 or Hg(BAL glucoside)2.
In dogs there was definite evidence that BAL glucoside was more effective than BAL in the treatment of both oral and intravenous mercury poisoning. This fact is chiefly of academic interest at the present time, inasmuch as BAL glucoside is not available in a sufficiently pure form to warrant clinical trial. However, it is not unlikely that compounds superior to BAL in protecting against the toxic effects of heavy metals would result from further investigations on dithiols.
Sufficient data are not available to account for the greater efficiency of the glucoside. However, certain conclusions may be drawn tentatively from observations on the toxicities of the preformed complexes. Hg(BAL)2 was no less toxic than HgCl2 on a molar basis. On the other hand, Hg-BAL glucoside was definitely less toxic than inorganic mercury. Inasmuch as the available data indicate that Hg-BAL glucoside dissociates to a greater extent than does Hg(BAL)2, one cannot relate the observed differences in toxicity to dissociability.
It is known that BAL is readily oxidized in the body. Therefore, the undiminished toxicity of BAL complexes could be explained by the intracellular oxidation of the complexes with the release of cationic mercury. In the treatment of mercury poisoning, a sustained concentration of BAL is maintained by repeated injections. Thus, a recombination of Hg++ released by oxidation with available BAL is possible. During the time that BAL is available, renal excretion of the complex can be effected. The fact that BAL promotes the excretion of arsenic (2, 3) and cadmium (6) has already been reported. Data on the effects of mercaptans on the excretion of other heavy metals are not yet available.
Danielli and coworkers (1) have suggested that BAL glucoside remains extracellular in its distribution. An extracellular volume distribution of the Hg-BAL glucoside complexes would explain their decreased toxicities. In keeping with this explanation, Hg(BAL glucoside)2, a compound of higher molecular weight than Hg-BAL glucoside, might be expected to penetrate cells more slowly and thus be less toxic. However, it must also be assumed that the difference in the degree of dissociation of the 2 complexes may play some role in their relative toxicities.
An extracellular distribution of a mercaptan would not preclude the possibility of the mercaptan's removing heavy metals from intracellular enzymes. A significant degree of dissociation of the metallo-enzyme complex would result in an appreciable concentration of diffusible cationic metal which would be available for combination with the mercaptan at an extracellular site to form a mercaptide of lower dissociability. Thus, a continuous removal of metal from the cell could be accomplished.
The fact that BAL, at dose levels within the range of human tolerance, is highly effective in preventing systemic effects of mercury following oral mercury poisoning in dogs provides the experimental background for the clinical use of BAL in mercury poisoning in humans. In the above study, none of the dogs received the adjuvant and supportive therapy which would be afforded human patients. Thus in the majority of animals, the metabolic disturbances resulting from the severe diarrhea, which was invariably present before delayed treatment was initiated, could only. be corrected by voluntary ingestion of food and water, and adequate renal function. The fact that treatment was so efficacious that a majority of dogs survived even when therapy was delayed for 5 hours, attests to the value of BAL in the treatment of mercury poisoning more convincingly than if 100 per cent survived with the aid of intensive local and supportive therapy. In support of this statement is the fact that in only 1 instance did an orally poisoned, BAL-treated dog die in uremia. 5. The reactions between mercaptans and mercury in vitro have been studied, and tentative formulae for the mercaptides formed have been presented. The toxicities of the preformed mercaptides have been determined, and the mechanism of action of mercaptans in detoxifying mercury discussed in the light of these data.
